It was approved for certain types of cancers and has slowly been approved for more and more types of cancer, basically. > Dec 21, 2020 Approval Tagrisso Approv

It was approved for certain types of cancers and has slowly been approved for more and more types of cancer, basically. > Dec 21, 2020 Approval Tagrisso Approved in the US for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Non-Small Cell Lung Cancer > Apr 18, 2018 Approval FDA Approves Tagrisso (osimertinib) as First-Line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer > Jun 6, 2017 AstraZeneca Presents Tagrisso (osimertinib) Data in Patients with EGFR T790M-Mutation Positive Lung Cancer and Central Nervous System Metastases > Mar 31, 2017 Approval Tagrisso (osimertinib) Receives FDA Full Approval > Nov 13, 2015 Approval FDA Approves Tagrisso (osimertinib) for EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer https://www.drugs.com/history/tagrisso.html https://www.drugs.com/history/tagrisso.html